Meeting News

Test combining fundus, OCT imaging improves AMD diagnosis

November 13, 2019
SAN FRANCISCO — A screening strategy combining fundus and OCT imaging improved the accuracy of age-related macular degeneration classification…
Meeting NewsVideo

VIDEO: Gene therapy for wet AMD ‘on the horizon’

November 11, 2019
SAN FRANCISCO — In the OPTIC trial, patients with wet age-related macular degeneration who were treated with ADVM-022, an intravitreal gene…
Meeting News

OpRegen subretinal transplantation appears well-tolerated in dry AMD

November 7, 2019
SAN FRANCISCO — OpRegen, a human embryonic stem cell-derived retinal pigment epithelial cell therapy transplanted subretinally, appeared…
Meeting News

Beovu improves visual acuity in AMD, polypoidal choroidal vasculopathy

October 29, 2019
SAN FRANCISCO — Treatment with Beovu resulted in visual acuity letter gains among patients with age-related macular degeneration and polypoidal…
Meeting NewsVideo

VIDEO: Improvements maintained for 2 years with abicipar for wet AMD

October 28, 2019
SAN FRANCISCO — Rahul Khurana, MD, of Northern California Retina Vitreous Associates, shared the 2-year results from the CEDAR and SEQUOIA…
Meeting NewsVideo

VIDEO: Novel anti-VEGF therapy shows ‘promising’ durability for wet AMD

October 24, 2019
SAN FRANCISCO — In a new phase 1b trial, KSI-301, an antibody biopolymer conjugate that blocks VEGF isoforms, demonstrated strong durability…

Faricimab demonstrates durable Ang-2, VEGF suppression

October 15, 2019
SAN FRANCISCO — Faricimab demonstrated sustained inhibition of both angiopoietin-2 and VEGF-A in patients with neovascular age-related macular…

Port delivery system reduces treatment burden in AMD

October 15, 2019
SAN FRANCISCO — A port delivery system device with ranibizumab was effective, well tolerated and required infrequent refills in patients with…